Browsing by Author Jackson, Miriam

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2016Ablation of Perlecan domain I heparan sulfate reduces progressive cartilage degradation, synovitis, and osteophyte size in post-traumatic osteoarthritisJackson, Miriam; Little, Christopher; Melrose, James; Shu, Cindy; Smith, Margaret; Smith, Susan; Lord, Megan; Penm, Steven; Whitelock, John M.; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Surgery; Northern Clinical School: Inst. for Bone & Joint Research; Northern Clinical School: Inst. for Bone & Joint Research; Northern Clinical School: Inst. for Bone & Joint ResearchAblation of Perlecan domain I heparan sulfate reduces progressive cartilage degradation, synovitis, and osteophyte size in post-traumatic osteoarthritis, Arthritis & Rheumatology, vol.68, 4, 2016,pp 868-879
2009Activation of Cartilage Matrix Metalloproteinases by Activated Protein CJackson, Christopher; Jackson, Miriam; Little, Christopher; Smith, Margaret; Smith, Susan; Xue, Meilang; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Surgery; Northern Clinical School: Inst. for Bone & Joint Research; Northern Clinical School: Inst. for Bone & Joint Research; Northern Clinical School: MedicineActivation of Cartilage Matrix Metalloproteinases by Activated Protein C, Arthritis and Rheumatism, vol.60,(3),2009,pp 780-791
2014Activation of matrix metalloproteinases 2, 9, and 13 by activated protein c in human osteoarthritic cartilage chondrocytesBabak, Moradi; Jackson, Christopher; Jackson, Miriam; Little, Christopher; Smith, Margaret; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Inst. for Bone & Joint ResearchActivation of matrix metalloproteinases 2, 9, and 13 by activated protein c in human osteoarthritic cartilage chondrocytes, Arthritis & Rheumatology, vol.66, 6, 2014,pp 1525-1536
2014Depletion of protease-activated receptor 2 but not protease-activated receptor 1 may confer protection against osteoarthritis in mice through extracartilaginous mechanismsJackson, Christopher; Jackson, Miriam; Little, Christopher; McCracken, Sharon Anne; Moradi, Babak; Smith, Margaret; Smith, Susan; Zaki, Sanaa; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Inst. for Bone & Joint Research; Northern Clinical School: Inst. for Bone & Joint Research; Vet Science FacultyDepletion of protease-activated receptor 2 but not protease-activated receptor 1 may confer protection against osteoarthritis in mice through extracartilaginous mechanisms, Arthritis & Rheumatology, vol.66, 12, 2014,pp 3337-3348
2011Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritisChan, Benjamin; Fuller, Emily; Jackson, Miriam; Little, Christopher; Russell, A; Sambrook, Philip; Smith, Margaret; Smith, Susan; Bateman, John F; Cake, M A; Read, R. A.; Northern Clinical School: Surgery; Northern Clinical School: Inst. for Bone & Joint Research; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Inst. for Bone & Joint Research; Northern Clinical School: Inst. for Bone & Joint ResearchIncreased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis, Osteoarthritis and Cartilage, vol.19, 7, 2011,pp 874-885
2014Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib)Deo, Nikita; El-Hoss, Jad; Jackson, Miriam; Little, Christopher; Little, David; Schindeler, Aaron; Kolind, Mille; McDonald, Michelle; Mikulec, Kathy; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child HealthModulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib), Bone, vol.59, N/A, 2014,pp 151-161